Introduction
============

Mitochondrial and free radical theories of aging suggest that there is an imbalance between the activity of free radical generation and the endogenous radical scavenging system in brain disorders \[[@b1], [@b2]\] resulting in an impairment of ATP production \[[@b3], [@b4]\]. In this regard, mitochondria are not only intracellular generators of the reactive oxygen species (ROS) but also immediate targets of oxidative damage \[[@b5]--[@b8]\]. ROS are generated at sites of inflammation and injury. At low levels, they can function as signalling intermediates in the regulation of fundamental cell activities such as growth and adaptation responses. At higher concentrations, ROS can cause cell injury and death. This occurs during the aging process, where oxidative stress is incremented due to an accelerated generation of ROS and a gradual decline in cellular antioxidant defence mechanisms. Consequently, aging and the associated increase in oxidative stress are major risk factors for many neurodegenerative diseases \[[@b9]\]. Compared to other organs or tissues, the brain is more vulnerable to ROS-induced damage due to its high rate of oxygen consumption, high polyunsaturated lipid content and relative weariness of classic antioxidant enzymes \[[@b10], [@b11]\].

Organisms utilize antioxidant defence, including enzymes like superoxide dismutase (SOD), which converts O^2.−^ into H~2~O~2~, catalase (CAT), that is responsible for the detoxification of H~2~O~2~ and GPx, that breaks down peroxides. The ATP metabolism is tightly coupled to the PCr metabolism *via* the enzyme system of creatine kinase (CK), which plays a central role in energy transfer in cells with high energy requirements and which is very susceptible to oxidative stress \[[@b12], [@b13]\]. Rate constant of CK reaction can be investigated by the magnetization transfer in vivo ^31^P magnetic resonance spectroscopy (MRS) experiment \[[@b14], [@b15]\]. The investigation of the kinetic parameter *kfor* using *in vivo* ^31^P MR spectroscopy magnetization transfer method contributes to better understanding of the underlying processes in age-dependent brain disorders. This technique can be used as a non-invasive *in vivo* biomarker for age-related neurodegenerative diseases as it can reveal energy metabolism impaired in brain tissue, which is not detectable by conventional MRS methods. By means of this technique we studied reaction kinetics of reversible exchange of the phosphate group in the reaction catalysed by CK in the brain of rats \[[@b9]\]. Moreover, mitochondrial oxidative phosphorylations (OXPHOS) as well as endogenous enzymatic antioxidant activities in the brain and peripheral blood of young, adult and aged rats were investigated in this study.

Materials and methods
=====================

Animals
-------

Young (3 months old), adult (17 months old) and aged (36 months old), male Wistar rats supplied by Velaz (Prague, Czech Republic) were housed at 22 ± 2°C, 45% relative humidity, 12-hr light/dark photoperiodicity in air-conditioned rooms with free access to standard commercial laboratory pellets ST1 (Tp Dovo, Slovak Republic) and water ad libitum. All animals received human care in compliance with the Institutional Animal Ethic Committee and with the Guidelines of European Convention for the Protection of Vertebrate Animals Used for Experimental Purposes.

Methods
-------

### *In vivo* ^31^P magnetic resonance spectroscopy

Phosphorous saturation transfer experiments were performed on a 4.7 T 200 Mhz SISCO imaging spectrometer equipped with a horizontal magnet at 81 MHz. A three-turn 1.6-cm-diameter surfaře coil was positioned over the skull of an animal anesthetized by 0.8--1.0% of halothane. First, the static magnetic field was shimmed using proton signals which showed a typical line width of 20--35 Hz. Then, the phosphorous flip angle was adjusted to minimize the broad signal coming from the bone. The time of irradiation of γ-ATP resonance was varied from 0.3 to 1.6 sec., which resulted in an exponential decay of PCr signal to a steady-state value. The saturation was accomplished by an on-resonance series of 10 msec. DANTE pulses with interpulse delays of 400 msec. \[[@b16]\]. Either 96 or 128 transients were accumulated in the interleave mode with a repetition of 5 sec. \[[@b17]\].

### *In vitro* mitochondrial respiration

The rats were euthanized with i.p. injection of Thiopental (Spofa, Czech Republic, 150 mg/kg b.w.). Removed brain tissue was placed on ice-cold isolation solution containing (in mmol/l) 225 manitol, 75 sucrose, 0.2 ethylenediaminetetraacetic acid (EDTA); pH 7.4. Tissue sample was minced and homogenized in the solution using a glass-teflon homogenizer. Brain mitochondria were isolated at 4°C by differential centrifugation \[[@b18]\]. Mitochondrial protein concentration was estimated by the method of Lowry \[[@b19]\] using bovine serum albumin as a standard. Respiratory chain function was measured in a respiratory buffer containing (in mmol/l) 12.5 HEPES, 3 KH2PO4, 122 KCl, 0.5 EDTA and 2% dextran; pH 7.2 at 30°C, by means of Oxygraph Gilson 5/6H (Madison, WI, USA) using Clark-type oxygen electrode. Sodium glutamate/malic acid (2.5 mmol/2.5 mmol) were used as a nicotinamide adenine dinucleotide (NAD) substrate for complex I and succinate (5 mmol) as a FAD substrate for complex II. To initiate state 3 respiratory activity, 500 nmol of ADP were added to the cuvette. When all the ADP was converted to ATP, state 4 respiration was measured. Parameters of OXPHOS, such as QO2(S3) \[nAtO mg/prot/min.\], *i.e.* oxygen consumption rate in presence of ADP (state S3); QO2S4 \[nAtO mg/prot/min.\], oxygen consumption rate without ADP (S4); RCR \[S3/S4\], respiratory control ratio; ADP:O (nmol ADP/nAtO\], coefficient of OXPHOS and OPR \[nmol ATP mg prot/min\], OXPHOS rate, were determined, respectively.

### Endogenous antioxidants

The enzymatic activity of SOD was determined using a RANSOD kit (Randox Labs, San Diego, CA, USA). CAT activity was determined as described by Aebi \[[@b20]\], glutathione peroxidase (GPx) activity according to Wendel \[[@b21]\], the ferric reducing ability of plasma (FRAP) according to Benzie \[[@b22]\] and ceruloplasmin (CPL) according to Schosinsky \[[@b23]\].

Statistical methods
-------------------

The results were evaluated using ANOVA and Student's t-test for unpaired data; the Sudent's t-test was used to compare differences between groups. Calculated values were expressed as means ± S.E.M.. P-values were considered as a significant (\**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001).

Results
=======

Brain bioenergetic parameters were evaluated on young (3 months old), adult (17 months old) and aged (36 months old) male Wistar rats using *in vivo* ^31^P MRS and *in vitro* polarographic analysis of mitochondrial OXPHOS, respectively.

*In vivo* ^31^P magnetic resonance spectroscopy
-----------------------------------------------

Relative concentrations of phosphate metabolism were determined from integrals of their signal in ^31^P MR spectra using program MESTREC-C 1.5.1 ([Table 1](#tbl1){ref-type="table"} and [Fig. 1](#fig01){ref-type="fig"}). Time-dependent ^31^P MRS saturation transfer was applied to determine the pseudo-first-order rate constant of forward CK reaction (*kfor*). While the analysis of steady-state 31P MR spectra revealed significant increase in the ratio of PCr/ATP (*P* \< 0.001), PCr/Pi (*P* \< 0.01) and PME/ATP (*P* \< 0.05), we found significant (*P* \< 0.001) decrease of forward kfor in aged rats as compared to the young group.

###### 

Brain bioenergetic measurements in young (3 months old) and aged (36 months old) rats by using 31P NMR spectroscopy

  **Age**     **PCr/ATP**           **PCr/Pi**          **PME/ATP**       **kfor**              **pHi**
  ----------- --------------------- ------------------- ----------------- --------------------- -----------------
  3 months    1.94 ± 0.06           4.14 ± 0.42         0.77 ± 0.09       0.35 ± 0.02           7.18 ± 0.01
  36 months   2.12 ± 0.04^\*\*\*^   5.64 ± 1.44^\*\*^   0.84 ± 0.07^\*^   0.30 ± 0.01^\*\*\*^   7.16 ± 0.01^\*^

Data are presented as mean ± S.E.M., ^\*\*\*^*P* \< 0.001, ^\*\*^*P* \< 0.01, ^\*^*P* \< 0.05 *versus* 3 months.

Note: Adult (17 months old) rats were not measured due to disruptions in SISCO spectrometer.

![Changes of brain bioenergetics measured *in vivo* by ^31^P MRS in aged (36 months old) compared to young (3 months old) male Wistar rats. MRS, magnetic resonance spectroscopy; PCr/ATP, phosphocreatine to adenosine three phosphate ratio; PCr/Pi, PCr to inorganic phosphate ratio; PME/ATP, phosphate monoester to ATP ratio; *kfor*, forward rate constant of CK and pHi, intracellular pH. \*\*\**P* \< 0.001, \*\**P* \< 0.01, \**P* \< 0.05.](jcmm0014-2667-f1){#fig01}

*In vitro* mitochondrial oxidative phosphorylation ([Table 2](#tbl2){ref-type="table"} and [Fig. 2](#fig02){ref-type="fig"})
----------------------------------------------------------------------------------------------------------------------------

###### 

Age-dependent mitochondrial OXPHOS activities in young (3 months), adult (17 months) and aged (36 months) male Wistar rats

  **Parameters OXPHOS**            **Age**                                                                                           
  -------------------------------- --------------- --------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------
  Complex I                                                                                                                          
  RCI (S3.S4--1)                   3.63 ± 0.19     3.25 ± 0.12                                                                       2.86 ± 0.08[\*](#tf2-1){ref-type="table-fn"}^+^
  ADP:O (nmol ADP.nAtO-1)          2.67 ± 0.02     2.76 ± 0.02[\*](#tf2-1){ref-type="table-fn"}                                      2.63 ± 0.04^+^
  QO2S3 (nAtO.mg prot-1.min-1)     76.73 ± 2.80    58.74 ± 2.89[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}    48.68 ± 1.76[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}^+^
  QO2S4 (nAtO.mg prot-1.min-1)     21.98 ± 1.52    18.16 ± 0.75                                                                      17.14 ± 0.80
  OPR (nmol ATP.mg prot-1.min-1)   205.23 ± 6.08   163.97 ± 9.35[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}   127.27 ± 5.26[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}^++^
  Complex II                                                                                                                         
  RCI (S3.S4--1)                   1.66 ± 0.33     1.65 ± 0.06                                                                       1.64 ± 0.04
  ADP:O (nmol ADP.nAtO-1)          1.69 ± 0.03     1.63 ± 0.04                                                                       1.72 ± 0.03
  QO2S3 (nAtO.mg prot-1.min-1)     87.87 ± 4.36    68.20 ± 3.97[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}    51.04 ± 2.72[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}^++^
  QO2S4 (nAtO.mg prot-1.min-1)     53.02 ± 2.93    41.66 ± 2.75[\*](#tf2-1){ref-type="table-fn"}                                     31.33 ± 1.99[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}^+^
  OPR (nmol ATP.mg prot-1.min-1)   205.23 ± 6.08   163.97 ± 9.35[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}   127.27 ± 5.26[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}^++^

Data are presented as mean ± S.E.M.

[\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}*P* \< 0.001, [\*](#tf2-1){ref-type="table-fn"}[\*](#tf2-1){ref-type="table-fn"}*P* \< 0.01, [\*](#tf2-1){ref-type="table-fn"}*P* \< 0.05 *versus* 3 month, ^++^*P* \< 0.01, ^+^*P* \< 0.05 *versus* 17 month.

![Percentual changes of *in vitro* measured OXPHOS parameters in brain mitochondria from young (3 months old), adult (17 months old) and aged (36 months old) male Wistar rats. (A) Complex I--sodium glutamate / malic acid NAD substrate, (B) Complex II--succinate FAD substrate (respectively, A and B). \*\*\**P* \< 0.001, \*\**P* \< 0.01, \**P* \< 0.05 *versus* 3 months old rats. ++*P* \< 0.01, +*P* \< 0.05 *versus* 17 months old rats.](jcmm0014-2667-f2){#fig02}

2 days after ^31^P MR spectroscopy, the rats were killed and brains were removed for biochemical investigations. Polarographic analysis of OXPHOS was performed on mitochondria isolated from the forebrain of young (3 months old), adult (17 months old) and aged (36 months old) rats. State 3 respiration (QO2S3) was started by the addition of ADP to mitochondria respiring with substrates. When measured in complex I and in complex II, the ADP-stimulated state 3 respiration significantly decreased by 23% and by 22% in adult (*P* \< 0.01), and by 37% and 42% (*P* \< 0.001) in aged rats as compared with young rats, respectively. Respiratory control index (RCI), as indicator of mitochondrial membrane integrity was found to be significantly decreased by 21% (*P* \< 0.05) only in the complex I of aged rats. There were no significant differences in state 4 respiration in complex I, however, in complex II state 4 respiration was decreased significantly by 21% in adult (*P* \< 0.05) and by 41% (*P* \< 0.001) in aged rats. Coefficient of OXPHOS (ADP:O) as an indicator of coupling oxidation and phosphorylation showed some changes in complex I, but not in complex II. Significant decrease in rates of OXPHOS and ATP production (OPR) by 20% and 23% (*P* \< 0.01) in adult and by 38% and 37% (*P* \< 0.001) in aged rats is suggested to be the consequence of age-related decrease in state 3 respiration.

Endogenous antioxidants ([Table 3](#tbl3){ref-type="table"} and [Fig. 3](#fig03){ref-type="fig"})
-------------------------------------------------------------------------------------------------

###### 

Brain and blood antioxidant measurements in adult (10 months old) and aged (36 months old) rats

                      **Age**             
  ------------------- ------------------- --------------------------
  **Brain**                               
  SOD (U.g-1)         170.73 ± 21.43      160.63 ± 8.15
  CAT (U.ml-1)        3.63 ± 0.42         4.59 ± 0.16
  GPX (U.g-1)         0.84 ± 0.14         1.34 ± 0.16^\*^
  GST (U.g-1)         2.69 ± 0.17         3.09 ± 0.06^\*^
  FRAP (mmol.g-1)     4.64 ± 0.27         4.87 ± 0.06
  CPL (U.g-1)         0.52 ± 0.04         0.07 ± 0.02^\*\*\*^
  **Blood**                               
  SOD e(U.ml-1)       197.03 ± 11.06      179.83 ± 8.06
  CAT e(U.ml-1)       1232.68 ± 143.68    3928.88 ± 155.88^\*\*\*^
  GPXe(U.ml-1)        8.83 ± 0.33         3.14 ± 0.03^\*\*\*^
  GST e(U.ml-1)       3.84 ± 0.36         5.70 ± 0.37^\*\*^
  FRAP p(mmol.ml-1)   363.34 ± 32.18...   315.50 ± 18.90
  CPL p (U.ml-1)      0.14 ± 0.02         0.11 ± 0.01

Data are presented as mean ± S.E.M. ^\*\*\*^*P* \< 0.001, ^\*\*^*P* \< 0.01, ^\*^*P* \< 0.05.

![Percentual changes of endogenous antioxidants activity in brain tissue (A) and in peripheral blood (B) of aged (36 months old) compared to adult (10 months old) male Wistar rats. (A) (brain) \*\*\**P* \< 0.001, \**P* \< 0.05, (B) (blood) \*\*\**P* \< 0.001, \*\**P* \< 0.01.](jcmm0014-2667-f3){#fig03}

The aim of the present study was to investigate the FRAP along with antioxidant enzyme activities and CPL. This analysis has revealed an significant (*P* \< 0.05) increase of GPX and GST activity and significant (*P* \< 0.001) decrease of CPL level in the brain as well as significant increase of CAT (*P* \< 0.001) and GST (*P* \< 0.01) activity and decrease of GPX (*P* \< 0.001) activity in plasma of aged rats. As a result, antioxidant power (FRAP) of the brain and plasma was not disturbed in aged rats.

Discussion
==========

It is well documented that age-related neurogenic dementia is a major risk factor in the lifespan of human beings and animals \[[@b24]--[@b27]\]. In aerobic cells, 90--95% of the total amount of ATP production comes from aerobic metabolism. The synthesis of ATP *via* the mitochondrial respiratory chain is the result of the electron transport coupled to OXPHOS \[[@b28]\]. During normal aging and due to the emergence of some neurodegenerative diseases like AD, damaged mitochondria are unable to maintain the energy demands of the cell \[[@b29]--[@b31]\]. This can lead to an increased production of free radicals, which induces the interruption of OXPHOS and results in decreased levels of ATP \[[@b32]\]. Excitotoxicity, advanced age, oxidative stress, hypertension, mitochondrial dysfunction, free radical-induced oxidative damage have all been implicated in the pathogenesis of several different neurodegenerative diseases in addition to AD, and include Huntington's disease, Parkinson's disease, amyotrophic lateral sclerosis and Schizophrenia \[[@b33]\]. The main radical produced by mitochondria is the superoxide anion; intra mitochondrial antioxidant systems scavenge this radical to avoid oxidative damage, which can lead to impaired ATP production \[[@b4], [@b24], [@b30], [@b32], [@b34], [@b35]\].

Neurons are very sensible to oxidative stress due to their high demand for energy. Most of the energy is derived from the metabolism of glucose to carbon dioxide and water through the glycolysis and mitochondrial OXPHOS \[[@b36]\]. The ATP production and utilization is fundamental in cerebral bioenergetics \[[@b37]--[@b39]\]. The brain ATP metabolism is mainly controlled by ATPase and CK reactions of PCR\< = \>ATP\< = \>Pi chemical exchange systems \[[@b40], [@b41]\]. In our ^31^P MRS study, performed on young (3 months) and aged (36 months) rats, we found significantly increased ratios of PCr to ATP (*P* \< 0.001), PCr to Pi (*P* \< 0.01) and PME to ATP (*P* \< 0.05).

The kinetics of ATP metabolism and the associated chemical exchange rates should be more sensitive to brain energy states than the steady-state ATP concentration \[[@b42], [@b43]\]. CK plays a fundamental role in cellular energetics of the brain. The forward rate constant (*kfor*) of the CK can be used as an indicator of brain metabolic changes. In our study, *kfor* was found to be significantly (*P* \< 0.001) diminished in the brain of aged rats compared to young rats. We assume that *kfor* of CK in the brain could serve as a sensitive early *in vivo* MRS biomarker of brain disorders. The results of ^31^P MRS correspond with the results of *in vitro* mitochondrial OXPHOS assessed polarographically in the brain of rats. These results support the hypothesis that impairment of mitochondrial respiration may be a causal factor of the aging process, and that such impairment may be result from increased H~2~O~2~ production *in vivo*\[[@b18]\]. Our findings suggest that the CK reaction could play a key role in the energetic system of young and aged rat brains.

Progressive age-related significant decrease of oxygen uptake (QO2S3) and ATP synthesis (OPR) describe the condition of mitochondrial dysfunction. Age-related cerebral disorders are usually accompanied by oxidative stress \[[@b44]\] and perturbation of the cellular oxidant/antioxidant balance \[[@b45], [@b46]\]. The brain has relatively low levels of antioxidants \[[@b47], [@b48]\]. SOD-2 is a highly inducible mitochondrial protein synthesized within the cytosol \[[@b49], [@b50]\]. These consequences have been strongly implicated in the pathogenesis of human as well as animal models of neurodegenerative diseases \[[@b51]--[@b54]\], particularly AD \[[@b4], [@b24], [@b29], [@b30], [@b34], [@b35]\]. In our study, no significant differences in SOD expression were detectable between old (10 months) and aged (36 months) in rat brain homogenate and in peripheral blood (see [Table 3](#tbl3){ref-type="table"} and [Fig. 3](#fig03){ref-type="fig"}). The activity of GPX significantly increased (*P* \< 0.05) in the brain and decreased (*P* \< 0.001) in peripheral blood. The activity of GST significantly increased in brain (*P* \< 0.05) as well as in peripheral blood (*P* \< 0.01). The activity of CAT significantly increased (*P* \< 0.001) in blood only. However, age-related changes in brain oxidant enzyme activities remain controversial \[[@b55]\].

The high energy demand and lack of endogenous fuel reserves make the brain highly dependent upon continuous blood supply. Cerebrovascular lesions observed in aging are believed to be responsible for cognitive impairment \[[@b30], [@b31], [@b56]\] due to chronic hypoperfusion and suboptimal delivery of energy substrates \[[@b57], [@b58]\]. These observations demonstrate the importance of studying vascular alterations during aging. Clinical symptoms of vascular dementia are manifested when the amount of neuron loss has reached a threshold around 50--70%\[[@b59]\]. Our observations suggest that the mitochondria found in neurons, as well as in all of the brain cellular compartments (glia and vessels wall cells), are a primary target of brain damage due to their high energy demand and susceptibility to oxidation, leading to energy failure, and resulting in cognitive impairment and memory decline. Moreover, mounting evidence indicates that targeting mitochondria with antioxidants is a powerful form of treatment capable of restoring cell integrity and eliminating damage in the brain, resulting in significantly restored cognitive function and spatial memory. Therefore, *in vivo* 31P MRS and magnetic resonance imaging measurements are suitable to detect the disturbances early in the preclinical stage. Expanding feature research towards this avenue will open the doors for more and better treatment strategies developed towards aged associated neruodegenerative and cerebrovascular diseases.
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